journal article·2024-11-19

Photothermally Reinforced Nanozyme Remodeling Tumor Microenvironment of Redox and Metabolic Homeostasis to Enhance Ferroptosis in Tumor Therapy

Shuheng Qin, Hui-yue Zhao, Xing-yu Luo, Fei Wang, Jun Liu, Yin Ding, Yong Hu

ACS Nano· Volume 18· Issue 46
Publisher page

Abstract

The acidity and high GSH level in the tumor microenvironment (TME) greatly limit the antitumor activity of nanozymes. Thus, enhancing nanozymes’ activity is fundamentally challenging in tumor therapy. Although the combination of photothermal therapy (PTT) and nanozymes can enhance the catalytic activity, cancer cells will overexpress heat shock proteins (HSPs) at high temperature, aggravating the heat resistance of tumor cells, which in turn compromises the outcome of chemodynamic therapy. Herein, we propose an iron-doped metal–organic framework nanozyme (IB@Fe-ZIF8@PDFA) that can be activated under the weak acidity and high level of GSH, demonstrating the activities of GSH oxidation (GSH-OXD), peroxidase (POD), and NADH oxidase (NADH-OXD). Under laser irradiation, it displays photothermal-enhanced multienzyme activities to simultaneously eliminate tumors and inhibit tumor metastasis. While consuming endogenous GSH, IB@Fe-ZIF8@PDFA promotes the decomposition of H 2 O 2 into ·OH, enhancing ferroptosis in tumor cells. Surprisingly, IB@Fe-ZIF8@PDFA nanozyme can oxide NADH and subsequently limit the ATP supply, reducing the expression of HSPs and significantly weakening the heat resistance of tumor cells during PTT. Meanwhile, H 2 O 2 is generated during this procedure, which can endogenously replenish the consumed H 2 O 2 . Thus, this IB@Fe-ZIF8@PDFA nanozyme constitutes a self-cascading platform to consume GSH and NADH, endogenously replenish the H 2 O 2 and continuously generate ·OH to facilitate ferroptosis by disrupting the redox and metabolic homeostasis in tumor cells, achieving tumor elimination and tumor metastasis inhibition.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Engineering and Applied Sciences, MOE Key Laboratory of High Performance Polymer Materials & Technology, Nanjing University, Nanjing 210033, China

Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210093, China

Department of Laboratory Medicine, Wuxi No. 5 People’s Hospital Affiliated Jiangnan University, Wuxi, Jiangsu 214005, China

State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210033, China

Funding

Natural Science Foundation of Jiangsu Province · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China

References (40)

Show source-provided references
1. 10.1038/s41573-023-00723-410.1038/s41573-023-00723-4 ↗
2. 10.1039/D0CS00718H10.1039/D0CS00718H ↗
3. 10.1021/acsnano.2c1089310.1021/acsnano.2c10893 ↗
4. 10.1038/s41571-020-00462-010.1038/s41571-020-00462-0 ↗
5. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
6. 10.1016/j.biomaterials.2022.12183210.1016/j.biomaterials.2022.121832 ↗
7. 10.1016/j.cell.2013.12.01010.1016/j.cell.2013.12.010 ↗
8. 10.1016/j.cmet.2020.10.01110.1016/j.cmet.2020.10.011 ↗
9. 10.1021/acsnano.3c0136910.1021/acsnano.3c01369 ↗
10. 10.1021/acs.chemrev.8b0013810.1021/acs.chemrev.8b00138 ↗
11. 10.1002/adfm.20211043210.1002/adfm.202110432 ↗
12. 10.1039/c3cs35486e10.1039/c3cs35486e ↗
13. 10.1021/acsnano.8b0051610.1021/acsnano.8b00516 ↗
14. 10.1016/j.ccr.2019.05.01610.1016/j.ccr.2019.05.016 ↗
15. 10.1038/s41467-023-44656-310.1038/s41467-023-44656-3 ↗
16. 10.1021/jacs.1c0351010.1021/jacs.1c03510 ↗
17. 10.1002/anie.20221258910.1002/anie.202212589 ↗
18. 10.1038/s41580-020-00313-x10.1038/s41580-020-00313-x ↗
19. 10.1021/jacs.2c0960810.1021/jacs.2c09608 ↗
20. 10.1021/jacs.8b0445710.1021/jacs.8b04457 ↗
21. 10.1016/j.jhazmat.2021.12604610.1016/j.jhazmat.2021.126046 ↗
22. 10.1016/j.cej.2022.13572310.1016/j.cej.2022.135723 ↗
23. 10.1021/acscatal.6b0296610.1021/acscatal.6b02966 ↗
24. 10.1002/adma.20230314910.1002/adma.202303149 ↗
25. 10.1002/adma.20210011410.1002/adma.202100114 ↗
26. 10.1021/jacs.8b0358410.1021/jacs.8b03584 ↗
27. 10.1021/ic200478q10.1021/ic200478q ↗
28. 10.1002/adfm.20190795410.1002/adfm.201907954 ↗
29. 10.1039/D1NR06128C10.1039/D1NR06128C ↗
30. 10.1021/jacs.8b0358410.1021/jacs.8b03584 ↗
31. 10.1002/ange.20171014410.1002/ange.201710144 ↗
32. 10.1016/j.biomaterials.2021.12111010.1016/j.biomaterials.2021.121110 ↗
33. 10.1002/adma.20200338210.1002/adma.202003382 ↗
34. 10.1038/s41568-021-00378-610.1038/s41568-021-00378-6 ↗
35. 10.1039/C9CC07510K10.1039/C9CC07510K ↗
36. 10.1002/adma.20200243910.1002/adma.202002439 ↗
37. 10.3390/cells906150510.3390/cells9061505 ↗
38. 10.1002/anie.20200300410.1002/anie.202003004 ↗
39. 10.1002/anie.20210192410.1002/anie.202101924 ↗
40. 10.1002/adfm.20220634610.1002/adfm.202206346 ↗